Paul Cohen

34PUBLICATIONS
233CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 14, 2026
Using administrative health data to ascertain ovarian cancer treatment information in Australia: a validation against medical records.

|May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Jan 14, 2026
Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology Registry.

Mahendra Naidoo, Orla McNally, Clare L Scott

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Sep 02, 2025
Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study.

Kaamini Planisamy, Elena Ctori, Benhur Amanuel

Pageof 6

Frequent Collaborators

6 joint publications

Michael L Friedlander

5 joint publications

Martin Köbel

5 joint publications

Yee Leung

5 joint publications

Cassandra B Nichols